Tumor infiltrating lymphocytes as a predictive factor in Pertuzumab/Trastuzumab-treated HER2-positive breast cancer
2017 ◽
Vol 28
◽
pp. ix104
Kanako Saito
◽
Yuji Kotsuka
◽
Hiroyasu Oda
◽
Mikiya Ishihara
◽
Satoshi Tamaru
◽
...
2015 ◽
Vol 154
(2)
◽
pp. 239-249
◽
Shiwei Liu
◽
Xuening Duan
◽
Ling Xu
◽
Ling Xin
◽
Yuanjia Cheng
◽
...
2018 ◽
Vol 21
(1)
◽
pp. 45
Heejung Chae
◽
Changhoon Yoo
◽
Jung-A Yoon
◽
Hee Jin Lee
◽
Kyu-pyo Kim
◽
...
V Kotoula
◽
E Giannoulatou
◽
G Kouvatseas
◽
I Tikas
◽
G Lazaridis
◽
...
S Kurozumi
◽
K Inoue
◽
H Matsumoto
◽
Y Hayashi
◽
K Tozuka
◽
...
Jeeyeon Kim
◽
Ahrong Kim
◽
So Jeong Lee
2020 ◽
Vol 183
(3)
◽
pp. 599-606
Jing Zhao
◽
Jane Meisel
◽
Yi Guo
◽
Rita Nahta
◽
Kung Lin Hsieh
◽
...
2016 ◽
Vol 96
(2)
◽
pp. S44-S45
E.J. Yoshida
◽
Q. Li
◽
A. Chung
◽
B. Knudsen
◽
M. Burnison
◽
...
2015 ◽
Vol 33
(15_suppl)
◽
pp. 556-556
Jacques Raphael
◽
Inna Y Gong
◽
Sharon Nofech-Mozes
◽
John M. S. Bartlett
◽
Houman Nafisi
◽
...
2016 ◽
Vol 22
(23)
◽
pp. 5747-5754
◽
Barbara Ingold Heppner
◽
Michael Untch
◽
Carsten Denkert
◽
Berit M. Pfitzner
◽
Bianca Lederer
◽
...
Alexander S. Brodsky
◽
Jinjun Xiong
◽
Dongfang Yang
◽
Christoph Schorl
◽
Mary Anne Fenton
◽
...